JP2021523918A5 - - Google Patents
Info
- Publication number
- JP2021523918A5 JP2021523918A5 JP2020564243A JP2020564243A JP2021523918A5 JP 2021523918 A5 JP2021523918 A5 JP 2021523918A5 JP 2020564243 A JP2020564243 A JP 2020564243A JP 2020564243 A JP2020564243 A JP 2020564243A JP 2021523918 A5 JP2021523918 A5 JP 2021523918A5
- Authority
- JP
- Japan
- Prior art keywords
- crystalline form
- pyrazolo
- pyridine
- methyl
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023212606A JP2024037930A (ja) | 2018-05-18 | 2023-12-18 | Ｔｌｒ７／ｔｌｒ８阻害剤の結晶形態 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2018/087448 | 2018-05-18 | ||
| CN2018087448 | 2018-05-18 | ||
| PCT/IB2019/054066 WO2019220390A1 (en) | 2018-05-18 | 2019-05-16 | Crystalline forms of a tlr7/tlr8 inhibitor |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023212606A Division JP2024037930A (ja) | 2018-05-18 | 2023-12-18 | Ｔｌｒ７／ｔｌｒ８阻害剤の結晶形態 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021523918A JP2021523918A (ja) | 2021-09-09 |
| JP2021523918A5 true JP2021523918A5 (enExample) | 2022-05-20 |
| JP7407740B2 JP7407740B2 (ja) | 2024-01-04 |
Family
ID=67145832
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020564243A Active JP7407740B2 (ja) | 2018-05-18 | 2019-05-16 | Ｔｌｒ７／ｔｌｒ８阻害剤の結晶形態 |
| JP2023212606A Pending JP2024037930A (ja) | 2018-05-18 | 2023-12-18 | Ｔｌｒ７／ｔｌｒ８阻害剤の結晶形態 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023212606A Pending JP2024037930A (ja) | 2018-05-18 | 2023-12-18 | Ｔｌｒ７／ｔｌｒ８阻害剤の結晶形態 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US12084460B2 (enExample) |
| EP (1) | EP3793998A1 (enExample) |
| JP (2) | JP7407740B2 (enExample) |
| KR (1) | KR20210013554A (enExample) |
| CN (1) | CN112119078A (enExample) |
| AR (1) | AR117573A1 (enExample) |
| AU (1) | AU2019268583B2 (enExample) |
| BR (1) | BR112020022738A2 (enExample) |
| CA (1) | CA3097312A1 (enExample) |
| CL (1) | CL2020002967A1 (enExample) |
| MX (2) | MX2020012259A (enExample) |
| TW (2) | TW202417000A (enExample) |
| WO (1) | WO2019220390A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019155042A1 (en) | 2018-02-12 | 2019-08-15 | F. Hoffmann-La Roche Ag | Novel sulfone compounds and derivatives for the treatment and prophylaxis of virus infection |
| US12157746B2 (en) | 2018-06-05 | 2024-12-03 | Hoffmann-La Roche Inc. | Tetrahydro-1H-pyrazino[2,1-a]isoindolylquinoline compounds for the treatment of autoimmune disease |
| EP3807270B1 (en) | 2018-06-12 | 2023-09-13 | F. Hoffmann-La Roche AG | Novel heteroaryl heterocyclyl compounds for the treatment of autoimmune disease |
| US11952363B2 (en) | 2018-07-23 | 2024-04-09 | Hoffmann-La Roche Inc. | Piperazine compounds for the treatment of autoimmune disease |
| CN112638908A (zh) | 2018-09-04 | 2021-04-09 | 豪夫迈·罗氏有限公司 | 用于治疗自身免疫性疾病的苯并噻唑类化合物 |
| WO2020048596A1 (en) | 2018-09-06 | 2020-03-12 | F. Hoffmann-La Roche Ag | Novel pyrazolopyridine compounds for the treatment of autoimmune disease |
| EP3847170B1 (en) | 2018-09-06 | 2022-06-22 | F. Hoffmann-La Roche AG | Novel cyclic amidine compounds for the treatment of autoimmune disease |
| CN114599652B (zh) | 2019-10-31 | 2024-07-12 | 豪夫迈·罗氏有限公司 | 用于治疗自身免疫性疾病的氢吡嗪并[1,2-d][1,4]二氮杂䓬化合物 |
| EP4061816A1 (en) | 2019-11-19 | 2022-09-28 | F. Hoffmann-La Roche AG | Hydro-1h-pyrrolo[1,2-a]pyrazine compounds for the treatment of autoimmune disease |
| EP4061821B1 (en) | 2019-11-20 | 2025-08-06 | F. Hoffmann-La Roche AG | Spiro(isobenzofuranazetidine) compounds for the treatment of autoimmune disease |
| JP2023533807A (ja) | 2020-07-14 | 2023-08-04 | エフ． ホフマン－ラ ロシュ アーゲー | 自己免疫疾患の処置のためのヒドロイソキノリン又はヒドロナフチリジン化合物 |
| US11661431B2 (en) | 2021-04-16 | 2023-05-30 | Gilead Sciences, Inc. | Thienopyrrole compounds |
| TW202440078A (zh) | 2021-09-10 | 2024-10-16 | 美商基利科學股份有限公司 | 噻吩并吡咯化合物 |
| PE20250401A1 (es) * | 2021-09-24 | 2025-02-11 | Hoffmann La Roche | Compuestos de pirazolo[3,4-b]piridina para el tratamiento de enfermedades auto/inmunitarias |
| AU2023207313A1 (en) * | 2022-01-11 | 2024-06-13 | Novartis Ag | Tlr7/8-antagonist for treating sjögren's syndrome or mixed connective tissue disease |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11507052A (ja) | 1995-06-07 | 1999-06-22 | スージェン・インコーポレーテッド | キナゾリンおよび医薬組成物 |
| EP1940819A1 (en) | 2005-08-16 | 2008-07-09 | Memory Pharmaceuticals Corporation | Phosphodiesterase 10 inhibitors |
| EP3238722B1 (en) | 2011-01-10 | 2019-03-13 | Infinity Pharmaceuticals, Inc. | Solid forms of isoquinolinones |
| EA039373B1 (ru) | 2012-02-08 | 2022-01-19 | Янссен Сайенсиз Айрлэнд Юси | Производные пиперидино-пиримидина для лечения вирусных инфекций |
| EA029281B1 (ru) | 2013-07-30 | 2018-03-30 | Джилид Коннектикут, Инк. | Полиморф ингибиторов syk |
| AU2016312011B2 (en) * | 2015-08-25 | 2021-02-04 | Beigene, Ltd. | Process for preparing Parp inhibitor, crystalline forms, and uses thereof |
| BR112018074911B1 (pt) * | 2016-06-30 | 2023-01-17 | Kimberly-Clark Worldwide, Inc. | Processo para fabricar um compósito de espuma e fibra, compósito de espuma e fibra, e, artigo absorvente |
| EP4059934B1 (en) * | 2016-09-09 | 2026-07-29 | Novartis AG | Compounds and compositions as inhibitors of endosomal toll-like receptors |
-
2019
- 2019-05-16 WO PCT/IB2019/054066 patent/WO2019220390A1/en not_active Ceased
- 2019-05-16 KR KR1020207032942A patent/KR20210013554A/ko not_active Ceased
- 2019-05-16 BR BR112020022738-2A patent/BR112020022738A2/pt not_active IP Right Cessation
- 2019-05-16 CN CN201980032642.0A patent/CN112119078A/zh active Pending
- 2019-05-16 EP EP19735624.9A patent/EP3793998A1/en not_active Withdrawn
- 2019-05-16 AR ARP190101308A patent/AR117573A1/es not_active Application Discontinuation
- 2019-05-16 AU AU2019268583A patent/AU2019268583B2/en not_active Ceased
- 2019-05-16 MX MX2020012259A patent/MX2020012259A/es unknown
- 2019-05-16 US US17/056,351 patent/US12084460B2/en active Active
- 2019-05-16 TW TW112150642A patent/TW202417000A/zh unknown
- 2019-05-16 JP JP2020564243A patent/JP7407740B2/ja active Active
- 2019-05-16 TW TW108116864A patent/TWI826446B/zh active
- 2019-05-16 CA CA3097312A patent/CA3097312A1/en active Pending
-
2020
- 2020-11-13 MX MX2023013584A patent/MX2023013584A/es unknown
- 2020-11-16 CL CL2020002967A patent/CL2020002967A1/es unknown
-
2023
- 2023-12-18 JP JP2023212606A patent/JP2024037930A/ja active Pending
-
2024
- 2024-08-06 US US18/795,371 patent/US20240391938A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2019283921B2 (en) | Indole carboxamide compounds useful as kinase inhibitors | |
| CN111315737B (zh) | 经砜吡啶烷基酰胺取代的杂芳基化合物 | |
| TWI287545B (en) | New pyridazin-3(2h)-one derivatives | |
| JP4142621B2 (ja) | 純結晶形態の５−クロロ−３−（４−メタンスルホニルフェニル）−６’−メチル−［２，３’］ビピリジニルおよび合成方法 | |
| CN110256421A (zh) | Kras-g12c抑制剂 | |
| AU2015335783B2 (en) | Tricyclic atropisomer compounds | |
| TW200526593A (en) | New pyridazin-3(2H)-one derivatives | |
| JP7007290B2 (ja) | デングウイルス複製阻害剤としての置換インドール化合物誘導体 | |
| JP2006503845A (ja) | Ｃｂ２受容体モジュレーターとしてのピリジン誘導体 | |
| JP2009515836A5 (enExample) | ||
| PT3013814T (pt) | Compostos de tetrahidrocarbazol e carbazol carboxamida substituídos úteis como inibidores de quinases | |
| CN116113416A (zh) | 四环类衍生物、其制备方法和其医药上的用途 | |
| JP2020507624A5 (enExample) | ||
| JP2005529084A (ja) | 結晶性パレコキシブナトリウム | |
| WO2024251080A1 (zh) | 3,4-二氢酞嗪-1(2h)-酮类衍生物及其制备方法和用途 | |
| CN104994851A (zh) | 作为crac通道抑制剂的基于吡唑基的甲酰胺i | |
| JP2016516691A (ja) | カリウムイオンチャネル阻害剤としてのイソキノリン | |
| JP2005529084A5 (enExample) | ||
| JP2008515980A (ja) | 閉塞性動脈疾患のためのアリールスルホンアミドぺリ置換二環式化合物 | |
| JP6473820B2 (ja) | 塩酸ヨンケナフィルの多形体及びその調製方法、組成物並びに用途 | |
| JP2004530706A (ja) | 純粋な結晶形態にある５−クロロ−３−（４−メタンスルホニルフェニル）−６’−メチル−［２，３’］ビピリジニル及び合成方法 | |
| CN104884058A (zh) | 作为crac通道抑制剂的基于吡唑基的甲酰胺ii | |
| EP3495350B1 (en) | Compound inhibiting formation of c-myc/max/dna complex | |
| KR20060127892A (ko) | 온단세트론의 신규한 다형 형태, 이의 제조방법, 이를 포함하는 약제학적 조성물 및 항구토제로서의 이의 용도 | |
| JP2023033316A (ja) | Ｒｈｏ関連コイルドコイル含有プロテインキナーゼの阻害剤 |